Website & contact details
- Group website
- The site of this company’s group or brand.
Advanz Pharma UK and Ireland Limited
- Incorporated
- 24 September 2015 (11 years)
- Previously known as
- Intercept Pharma UK & Ireland Ltd (until 23 August 2022)This list may be incomplete. See all names on Companies House
- Industry
- Wholesale of pharmaceutical goods (46460)
- Directors
- Simon Tucker
- Owned by
- Accounts type
- Full
- Region
- Greater London
- Address
- Dashwood House69 Old Broad StreetLondonEC2M 1QS
Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 14 October 2027
- Last conf. stmt
- 30 September 2026
Charges
- Total
- 1
- Outstanding
- 1
- Part satisfied
- 0
- Satisfied
- 0
Officers 3 active
Officer details are public data from the Companies House register.
Director · Appointed 6 February 2025
British
Born June 1982 (44)
British
Born February 1973 (53)
Tucker, Simon
Director · Appointed 1 July 2022
British
Born October 1974 (52)
Officer history (12 former)
6 February 2025
6 February 2025
31 December 2024
Resigned Barcelo Sanchez, Francisco Javier as Director
23 February 2024
23 February 2024
Resigned Notarianni, Giancarlo as Director
1 July 2022
1 July 2022
Resigned Van Weperen, Willem Wouter as Director
1 July 2022
1 July 2022
Resigned Gemellaro, Michael as Director
1 July 2022
1 July 2022
Appointed Barcelo Sanchez, Francisco Javier as Director
1 July 2022
Appointed Tucker, Simon as Director
29 October 2021
4 October 2021
Appointed Van Weperen, Willem Wouter as Director
20 May 2021
20 May 2021
Appointed Gemellaro, Michael as Director
26 March 2021
Resigned Kapadia, Sandip as Director
17 March 2021
9 May 2018
31 December 2017
Appointed Notarianni, Giancarlo as Director
31 December 2017
1 October 2017
1 October 2017
Appointed Kapadia, Sandip as Director
1 October 2017
Resigned Duncan, Barbara as Director
24 September 2015
Appointed Duncan, Barbara as Director
24 September 2015
24 September 2015
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 1 July 2022
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Private Limited Company
Reg. no. 02330913
Former controllers (1)
1 July 2022
Ceased Intercept Pharmaceuticals, Inc. — Owns 75–100% of shares
Group structure 10 companies
Ownership group derived from the Companies House PSC register
Advanz Pharma Europe Limited Owns 75–100% of shares
Advanz Pharma Generics (UK) Limited Owns 75–100% of shares
Advanz Pharma Services (UK) Limited Owns 75–100% of shares
Advanz Pharma UK and Ireland Limited This company Owns 75–100% of shares
Amdipharm Mercury Midco UK Limited Owns 75–100% of shares
Amdipharm UK Limited Owns 75–100% of shares
Correvio (UK) Ltd. Owns 75–100% of shares
Focus Pharmaceuticals Limited Owns 75–100% of shares
Mercury Pharmaceuticals Limited Owns 75–100% of shares
Financials
Latest accounts, made up to 31 December 2025, aren't available as data. See them on Companies House
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 14 July 2026 | Resolutions | |||
| 17 June 2026 | Registration of a charge | |||
| 12 November 2025 | Confirmation statement with no updates | 30 September 2025 | ||
| 30 September 2025 | Full accounts | 31 December 2024 | ||
| 20 February 2025 | Appointment of a director |
Some other companies at this address
Other companies in this industry
Guildford
London
Wokingham
London
Newtownards
East Kilbride
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →